Howard Larkin
Published: Friday, July 6, 2018
Due to its high absorption by melanin in the target tissues of the ciliary bodies, diode 810nm lasers made transscleral cyclophotocoagulation (TSCPC) less destructive than earlier lasers for treating glaucoma. Now micropulse laser technology may improve safety even more. Still, there may yet be a role for traditional diode lasers, according to presenters at the American Society for Cataract and Refractive Surgeons Glaucoma Day 2018 in Washington DC, USA.
Arguing for continued use of diode lasers, Jeffrey Kammer MD, of Vanderbilt Eye Institute, Nashville, Tennessee, USA, noted that the technology reliably reduces IOP and has a safety profile comparable to the gold standard procedures trabeculectomy and tube shunts. He said that concerns over drastic complications, especially phthisis, are overstated.
NO PHTHISIS
Dr Kammer referenced a prospective study involving 66 patients with neovascular glaucoma comparing diode TSCPC with the Ahmed shunt. Mean IOP was reduced 57% in the diode group compared with 48% in the shunt group. No phthisis cases occurred in the diode group and two in the shunt group (Yildirim, J Glaucoma, 2009).
“Even in the worst of the worst glaucoma, phthisis was not an issue,” Dr Kammer said. Other studies have shown diode TSCPC is safe in eyes with good vision, defined as 20/60 or better (Rotchford AP et al. Br J Ophthalmol 2010.), and even as a primary treatment, achieving visual acuity and IOP-lowering results comparable to medications in a contralateral eye study (Egbert PE et al. Arch Ophthalmol 2001).
Robert Noecker MD of Yale University and Quinnipiac University responded that micropulse laser technology is a better alternative because it is less likely to burn tissue.
“Diode might be okay for end-stage cases, but generally we want to ‘first do no harm’.”
REDUCING HEAT BUILD-UP
Micropulse lasers reduce IOP as much as diode lasers, with better success after 18 months, Dr Noecker said (Tan A et al. Clin Experiment Ophthalmol 2010;38(3):266-72). And rather than using a continuous burst of energy as does a traditional diode laser, micropulse technology pulses the laser, reducing heat build-up. According to a study at the National University Hospital in Singapore, diode laser tip temperature exceeds 550 degrees C, whereas micropulse laser tips peak at 35 degrees C.
This can cause burns, which lead to coagulative necrosis, which continues to progress indefinitely. The result is unstable IOP reduction, hypotony and even phthisis – which does happen, Dr Noecker said.
“You don’t want something you can’t reverse from overtreatment, and that is really the true problem with traditional transscleral.”
Robert Noecker: noeckerrj@gmail.com
Jeffery Kammer: jeffrey.kammer@vanderbilt.edu
Tags: lasers, ASCRS 2018
Latest Articles
Organising for Success
Professional and personal goals drive practice ownership and operational choices.
Read more...
Is Frugal Innovation Possible in Ophthalmology?
Improving access through financially and environmentally sustainable innovation.
Read more...
iNovation Innovators Den Boosts Eye Care Pioneers
New ideas and industry, colleague, and funding contacts among the benefits.
Read more...
From Concept to Clinic
Partnerships with academia and industry promote innovation.
Read more...
José Güell: Trends in Cornea Treatment
Endothelial damage, cellular treatments, human tissue, and infections are key concerns on the horizon.
Read more...
Making IOLs a More Personal Choice
Surgeons may prefer some IOLs for their patients, but what about for themselves?
Read more...
Need to Know: Higher-Order Aberrations and Polynomials
This first instalment in a tutorial series will discuss more on the measurement and clinical implications of HOAs.
Read more...
Never Go In Blind
Novel ophthalmic block simulator promises higher rates of confidence and competence in trainees.
Read more...
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Read more...